导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.97% | 1026/4982 |
| 近一周 | -1.94% | 1812/5419 |
| 近一月 | -8.51% | 4804/5423 |
| 近一季 | -12.48% | 3433/5358 |
| 近半年 | 10.14% | 1001/5131 |
| 近一年 | 15.24% | 1197/4733 |
| 近两年 | 79.33% | 1296/4208 |
| 近三年 | 56.19% | 929/3661 |
| 成立以来 | 408.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.18% 2534/5130 |
53.51% 936/5464 |
- - |
- - |
| 2025 | 25.15% 2676/5130 |
-1.07% 3932/4624 |
-4.43% 4326/4802 |
41.18% 729/4970 |
-6.25% 3833/5130 |
| 2024 | 12.90% 774/4618 |
-4.66% 2555/4340 |
-3.92% 2762/4442 |
22.21% 147/4550 |
0.85% 1300/4618 |
| 2023 | -25.42% 3165/4216 |
-4.11% 3169/3759 |
-6.57% 2709/3909 |
-14.45% 3296/4055 |
-2.68% 1171/4209 |
| 2022 | -19.95% 1161/3578 |
-19.44% 1801/2804 |
22.42% 27/3205 |
-14.54% 2263/3430 |
-5.03% 2616/3570 |
| 2021 | 17.47% 397/2717 |
-7.66% 1283/1745 |
21.39% 287/2232 |
6.67% 290/2560 |
-1.75% 1828/2708 |
| 2020 | 66.29% 340/1596 |
4.26% 176/1036 |
26.97% 399/1256 |
11.37% 562/1472 |
12.80% 817/1690 |
| 2019 | 68.49% 57/926 |
29.87% 450/3054 |
-0.52% 1576/3201 |
15.25% 85/939 |
13.16% 164/1014 |
| 2018 | -22.12% 210/668 |
- - |
- - |
- - |
-12.33% 2408/2977 |
| 2017 | 31.75% 53/531 |
- - |
- - |
- - |
- - |
| 2016 | -13.14% 201/455 |
- - |
- - |
- - |
- - |
| 2015 | 35.26% 273/433 |
- - |
- - |
- - |
- - |
| 2014 | 38.45% 67/432 |
- - |
- - |
- - |
- - |
| 2013 | 35.68% 43/398 |
- - |
- - |
- - |
- - |
| 2012 | -5.67% 443/459 |
- - |
- - |
- - |
- - |
| 2011 | -19.98% 102/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 银河蓝筹混合A VS. 长安宏观策略混合A(740001) |